Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74:229–263. https://doi.org/10.3322/caac.21834

Article  PubMed  Google Scholar 

Mehrotra R, Yadav K (2022) Cervical cancer: formulation and implementation of govt of India guidelines for screening and management. Indian J Gynecol Oncol 20:4. https://doi.org/10.1007/s40944-021-00602-z

Article  PubMed  Google Scholar 

Singh M, Jha RP, Shri N, Bhattacharyya K, Patel P, Dhamnetiya D (2022) Secular trends in incidence and mortality of cervical cancer in India and its states, 1990–2019: data from the Global Burden of Disease 2019 Study. BMC Cancer 22. https://doi.org/10.1186/s12885-022-09232-w

Kalyani R, Das S, Bindra Singh MS, Kumar H (2010) Cancer profile in the Department of Pathology of Sri Devaraj Urs Medical College, Kolar: a ten years study. Indian J Cancer 47:160–165. https://doi.org/10.4103/0019-509X.63011

Article  CAS  PubMed  Google Scholar 

Damata S, Ferreira J, Nicolás I, Estevas S, Estevas G, Lérias S et al (2021) P16 and HPV genotype significance in HPV-associated cervical cancer-a large cohort of two tertiary referral centers. Int J Mol Sci 22:2294. https://doi.org/10.3390/ijms22052294

Article  CAS  Google Scholar 

Kalyani, Raghuveer, Sheela (2020) Expression of P16 biomarker in squamous cell carcinoma of uterine cervix and its association with clinico-pathological parameters: a cross-sectional study. Biomed Res Ther. 7:3954–61. https://doi.org/10.15419/bmrat.v7i9.626

Smits VAJ, Cabrera E, Freire R, Gillespie DA. Claspin - checkpoint adaptor and DNA replication factor (2019) FEBS J 286:441–55.https://doi.org/10.1111/febs.14594

Hsiao H-W, Yang C-C, Masai H (2021) Roles of Claspin in regulation of DNA replication, replication stress responses and oncogenesis in human cells. Genome Instab Dis 2:263–280. https://doi.org/10.1007/s42764-021-00049-8

Article  CAS  Google Scholar 

Bianco JN, Bergoglio V, Lin Y-L, Pillaire M-J, Schmitz A-L, Gilhodes J et al (2019) Overexpression of Claspin and timeless protects cancer cells from replication stress in a checkpoint-independent manner. Nat Commun 10:910. https://doi.org/10.1038/s41467-019-08886-8

Article  CAS  PubMed  PubMed Central  Google Scholar 

Benevolo M, Musio A, Vocaturo A, Donà MG, Rollo F, Terrenato I et al (2012) Claspin as a biomarker of human papillomavirus-related high grade lesions of uterine cervix. J Transl Med 10:132. https://doi.org/10.1186/1479-5876-10-132

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kobayashi G, Sentani K, Babasaki T, Sekino Y, Shigematsu Y, Hayashi T et al (2020) Claspin overexpression is associated with high-grade histology and poor prognosis in renal cell carcinoma. Cancer Sci 111:1020–1027. https://doi.org/10.1111/cas.14299

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kobayashi G, Sentani K, Hattori T, Yamamoto Y, Imai T, Sakamoto N et al (2019) Clinicopathological significance of claspin overexpression and its association with spheroid formation in gastric cancer. Hum Pathol 84:8–17. https://doi.org/10.1016/j.humpath.2018.09.001

Article  CAS  PubMed  Google Scholar 

Babasaki T, Sentani K, Sekino Y, Kobayashi G, Thang Pham Q, Katsuya N et al (2021) (2021) Overexpression of claspin promotes docetaxel resistance and is associated with prostate-specific antigen recurrence in prostate cancer. Cancer Med 10(16):5574–5588. https://doi.org/10.1002/cam4.4113

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ulsamer A, Martínez-Limón A, Bader S, Rodríguez-Acebes S, Freire R, Méndez J et al (2022) Regulation of Claspin by the p38 stress-activated protein kinase protects cells from DNA damage. Cell Rep 40:111375. https://doi.org/10.1016/j.celrep.2022.111375

Article  CAS  PubMed  Google Scholar 

Schalper KA, Brown J, Carvajal-Hausdorf D, McLaughlin J, Velcheti V, Syrigos KN, et al (2015) Objective measurement and clinical significance of TILs in non-small cell lung cancer. J Natl Cancer Inst 107. https://doi.org/10.1093/jnci/dju435

Larre A, Fernandes RC, Gerbasi GJ, Carvalho FM (2023) Tumor-infiltrating lymphocytes and tumor-stroma ratio on early-stage cervix carcinoma: prognostic value of two distinct morphological patterns of microenvironment. Cureus 15:45148. https://doi.org/10.7759/cureus.45148

Article  Google Scholar 

Darragh TM, Colgan TJ, Cox T, Heller J, Henry DS, Luff MR (2013) The lower anogenital squamous terminology standardization project for HPV-associated lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology: background and consensus recommendations from the college of American pathologists and the American society for colposcopy and cervical pathology. Int J Gynecol Pathol 32:76–115

PubMed  Google Scholar 

Singh D, Vignat J, Lorenzoni V, Eslahi M, Ginsburg O, Lauby-Secretan B et al (2023) (2023) Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative. Lancet Glob Health 11(2):197–206. https://doi.org/10.1016/S2214-109X(22)00501-0

Article  Google Scholar 

Kobayashi G, Hayashi T, Sentani K, Babasaki T, Sekino Y, Inoue S et al (2022) Clinicopathological significance of claspin overexpression and its efficacy as a novel biomarker for the diagnosis of urothelial carcinoma. Virchows Arch 480:621–633. https://doi.org/10.1007/s00428-021-03239-7

Article  CAS  PubMed  Google Scholar 

Nicolás I, Saco A, Barnadas E, Marimon L, Rakislova N, Fusté P et al (2020) Prognostic implications of genotyping and p16 immunostaining in HPV-positive tumors of the uterine cervix. Mod Pathol 33:128–137. https://doi.org/10.1038/s41379-019-0360-3

Article  CAS  PubMed  Google Scholar 

Kulhan M, Bilgi A, Avci F, Ucar MG, Celik C, Kulhan NG (2023) Is HPV-negative cervical carcinoma a different type of cervical cancer? Eur Rev Med Pharmacol Sci 27:9205–12. https://doi.org/10.26355/eurrev_202310_33948

Singh P, Kaushik S, Thakur B, Acharya S, Bhardwaj A, Bahal N (2023) Evaluation of variable p16 immunostaining patterns, Ki-67 indices and HPV status in cervical SILs and squamous cell carcinomas: an institutional experience: an institutional experience. Indian J Pathol Microbiol 66:63–69. https://doi.org/10.4103/ijpm.ijpm_656_21

Article  PubMed  Google Scholar 

Spardy N, Covella K, Cha E, Hoskins EE, Wells SI, Duensing A et al (2009) Human papillomavirus 16 E7 oncoprotein attenuates DNA damage checkpoint control by increasing the proteolytic turnover of claspin. Cancer Res 69:7022–7029. https://doi.org/10.1158/0008-5472.CAN-09-0925

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kushwah AS, Masood S, Mishra R, Banerjee M (2024) Genetic and epigenetic alterations in DNA repair genes and treatment outcome of chemoradiotherapy in cervical cancer. Crit Rev Oncol Hematol 194:104240.https://doi.org/10.1016/j.critrevonc.2023.104240

Zeng Z, Wang W, Liu X, Wang G, Ren K, Zhang F et al (2023) Optimal cisplatin cycles in locally advanced cervical carcinoma patients treated with concurrent chemoradiotherapy. Clin Transl Oncol 25:2892–2900. https://doi.org/10.1007/s12094-023-03151-3

Article  CAS  PubMed  Google Scholar